Role of apolipoprotein C‐III overproduction in diabetic dyslipidaemia-Reference-Cited by-同舟云学术

Role of apolipoprotein C‐III overproduction in diabetic dyslipidaemia

Published:2019-08 Issue:8 Volume:21 Page:1861-1870
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Adiels Martin¹,Taskinen Marja‐Riitta²,Björnson Elias¹,Andersson Linda¹,Matikainen Niina²³,Söderlund Sanni²³,Kahri Juhani⁴,Hakkarainen Antti⁵⁶,Lundbom Nina⁵,Sihlbom Carina⁷,Thorsell Annika⁷,Zhou Haihong⁸,Pietiläinen Kirsi H.³⁵⁹,Packard Chris¹⁰,Borén Jan¹^ORCID

Affiliation:

1. Department of Molecular and Clinical Medicine, University of GothenburgSahlgrenska University Hospital Gothenburg Sweden

2. Research Program for Clinical and Molecular Metabolism, Faculty of MedicineUniversity of Helsinki Helsinki Finland

3. Endocrinology, Abdominal Center, Helsinki University HospitalUniversity of Helsinki Helsinki Finland

4. Department of Internal Medicine and RehabilitationHelsinki University Hospital Helsinki Finland

5. HUS Medical Imaging Center, Radiology, Helsinki University HospitalUniversity of Helsinki Helsinki Finland

6. Department of Neuroscience and Biomedical EngineeringAalto University School of Science Espoo Finland

7. Proteomics Core Facility, Sahlgrenska AcademyUniversity of Gothenburg Gothenburg Sweden

8. Merck Research LaboratoriesMerck & Co. Inc. Kenilworth New Jersey

9. Obesity Research Unit, Research Program for Clinical and Molecular Metabolism, Faculty of MedicineUniversity of Helsinki Helsinki Finland

10. Institute of Cardiovascular and Medical SciencesUniversity of Glasgow Glasgow UK

Funder

Hjärt-Lungfonden

Diabetesförbundet

Vetenskapsrådet

Stiftelsen för Strategisk Forskning

Sahlgrenska Universitetssjukhuset

Academy of Finland

Suomen Lääketieteen Säätiö

Novo Nordisk Fonden

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13744

Reference62 articles.

1. VLDL, Apolipoproteins B, CIII, and E, and Risk of Recurrent Coronary Events in the Cholesterol and Recurrent Events (CARE) Trial

2. LDL Containing Apolipoprotein CIII Is an Independent Risk Factor for Coronary Events in Diabetic Patients

3. Apolipoprotein C-III Levels and Incident Coronary Artery Disease Risk

4. APOC3 Loss-of-Function Mutations, Remnant Cholesterol, Low-Density Lipoprotein Cholesterol, and Cardiovascular Risk

5. Apolipoprotein CIII and N-terminal prohormone b-type natriuretic peptide as independent predictors for cardiovascular disease in type 2 diabetes

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Associations of Lipids and Lipid-Modifying Drug Targets With Type 2 Diabetes in the Chinese Population;JACC: Asia;2024-09

2. Interaction Between Primary Hyperlipidemias and Type 2 Diabetes: Therapeutic Implications;Diabetes Therapy;2024-07-30

3. Modification of lipoprotein metabolism and function driving atherogenesis in diabetes;Atherosclerosis;2024-07

4. Apolipoprotein-CIII O-Glycosylation Is Associated with Micro- and Macrovascular Complications of Type 2 Diabetes;International Journal of Molecular Sciences;2024-05-14

5. Elevated apolipoprotein C3 augments diabetic kidney disease and associated atherosclerosis in type 2 diabetes;JCI Insight;2024-05-14